Back
Atara Biotherapeutics Stock Price Chart
Sponsored
ATRA
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
ATRA
Atara Biotherapeutics
Last Price:
10.60
Seasonality Move:
16.06%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- The current trend is moderately bearish and ATRA is experiencing slight selling pressure.
Atara Biotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.95 | Sell |
20-day SMA: | 10.59 | Buy |
50-day SMA: | 9.14 | Buy |
200-day SMA: | 12.56 | Sell |
8-day EMA: | 11.39 | Sell |
20-day EMA: | 10.77 | Sell |
50-day EMA: | 9.79 | Buy |
200-day EMA: | 14.79 | Sell |
Atara Biotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.77 | Buy |
Relative Strength Index (14 RSI): | 51.56 | Buy |
Chaikin Money Flow: | -14360 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.82 - 11.78) | Buy |
Bollinger Bands (100): | (7.36 - 10.48) | Buy |
Atara Biotherapeutics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Atara Biotherapeutics Stock
Is Atara Biotherapeutics Stock a Buy?
- Atara Biotherapeutics share price is 10.68 while ATRA 8-day simple moving average is 11.95, which is a Sell signal.
- The stock price of ATRA is 10.68 while Atara Biotherapeutics 20-day SMA is 10.59, which makes it a Buy.
- Atara Biotherapeutics 50-day simple moving average is 9.14 while ATRA share price is 10.68, making it a Buy technically.
- ATRA stock price is 10.68 and Atara Biotherapeutics 200-day simple moving average is 12.56, creating a Sell signal.
ATRA Technical Analysis vs Fundamental Analysis
Sell
43
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy or a Sell?
-
Atara Biotherapeutics stock is rated a Sell
The current Atara Biotherapeutics [ATRA] share price is $10.68. The Score for ATRA is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Atara Biotherapeutics Stock Info
Market Cap:
61.51M
Price in USD:
10.68
Share Volume:
108.35K
Atara Biotherapeutics 52-Week Range
52-Week High:
39.50
52-Week Low:
6.50
Sell
43
Atara Biotherapeutics (ATRA)
is a Sell
Atara Biotherapeutics Share Price Forecast
-
What is the Atara Biotherapeutics stock price today?
The Atara Biotherapeutics stock price is 10.68 USD today. -
Will ATRA stock go up or go down?
Atara Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Atara Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics is overvalued.
Is Atara Biotherapeutics Stock a Buy?
- Atara Biotherapeutics share price is 10.68 while ATRA 8-day exponential moving average is 11.39, which is a Sell signal.
- The stock price of ATRA is 10.68 while Atara Biotherapeutics 20-day EMA is 10.77, which makes it a Sell.
- Atara Biotherapeutics 50-day exponential moving average is 9.79 while ATRA share price is 10.68, making it a Buy technically.
- ATRA stock price is 10.68 and Atara Biotherapeutics 200-day simple moving average is 14.79, creating a Sell signal.
Fundamental Analysis of Atara Biotherapeutics
Is Atara Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $13.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $56.86 per share, and a decrease next year of $2.21 per share.
Technical Analysis of Atara Biotherapeutics
Should I short Atara Biotherapeutics stock?
- ATRA Moving Average Covergence Divergence (MACD) indicator is 0.77, suggesting Atara Biotherapeutics is a Buy
- Atara Biotherapeutics Relative Strength Index (RSI) is 51.56, which suggest Atara Biotherapeutics is overbought
- The Bollinger Bands (25) for Atara Biotherapeutics is (8.82 - 11.78), which suggest Atara Biotherapeutics is a Buy
- The Bollinger Bands (100) for Atara Biotherapeutics is (7.36 - 10.48), which suggest Atara Biotherapeutics is a Buy
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.